Recently Funded Tyto Care Brings Handheld Telehealth Device to Light

Follow

With a fresh Series B financing round of $11 million, Israeli-based telemedicine startup Tyto Care is putting its own unique spin on the diagnostic device market. Backed by strategic investors like Cambia Health Solutions and Walgreens, Tyto Care is discussing its innovative product–deemed the “Swiss Army knife of handheld diagnostic devices”–with a number of digital health news resources.

Tyto Care’s solution combines a handheld device and online communication platform that is designed to facilitate secure and seamless interactions between patient and provider. The diagnostic handheld device can aid non-medical individuals (namely parents) in examining a child’s mouth, throat, eyes, heart sounds, lung sounds, temperature, skin and ears when traveling to the doctor’s office for an in-person visit is not possible. Doctors can conveniently guide users in performing these tests in real time or a “store and forward” method can be applied, whereby a doctor receives the results collected by Tyto Care’s device for remote viewing.

Tyto Care was co-founded by Dedi Gilad and Ofer Tzadik in 2012, with the goal of providing “connected examination technology” beyond the scope of just phone or video conferencing to patients and providers alike. After this third round of funding, Tyto Care is believed to have raised $18.5 million to date and final device approval from the US Food and Drug Administration is expected to be granted within the calendar year.

To read more about Tyto Care’s company background and current product version, check out the official website here.

With more than 85 healthcare companies in our client base today, DoseSpot is avidly helping digital health companies stay at the forefront of care with unique and customizable e-Prescribing solutions. We encourage you to read our recent Case Study with Intellivisit for more information!

SOURCES: GeekTime, MedCity News and MobiHealthNews 

DoseSpot is a Surescripts certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit http://www.DoseSpot.com.

The Wonderful World of Wearables: Truths and Fallacies

Follow

In today’s health space, there is no doubt that consumer expectations for sensor-laden gadgets are at an all-time high. While the wearables market continues to grow at a rapid pace, Sensoplex CEO Hamid Farzaneh states that there is still plenty of room for improvement. In a recent TechCrunch article, Farzaneh acknowledges the amazing accuracy of high-quality sensors, yet wearable products continue to be clunky and generate poor user experience. To make consumers’ wearable experiences as informative and beneficial as possible, Farzaneh tackles some major myths and misconceptions surrounding the health wearables market:

1. Battery Life 

Buyers of wearables are always looking for newer, sophisticated and accurate sensors that tend to require a lot more power—and consequently, a lot more space. The current state of battery technology means that any wearable with more than an accelerometer will need a decent-sized battery that must be recharged every few days. Such a battery will take up a significant portion of the available space in a wearable device. The more “bells and whistles” associated with a wearable, therefore, will greatly increase its overall size—leading to potential problems for consumers seeking small and sleek wearables.

2. The “Invisible Wearable”

The successful wearable, in the eyes of many wearable advocates, is one that is practically invisible. This notion has fed into announcements (including New York Times articles) about tattoo, stamp-sized or flexible sensors and devices that one can stick onto his/her skin to collection motion or bio-information. The reality is that sensors by no means complete systems—they simply capture raw data. The kind of ultra-thin devices being talked about simply cannot house the necessary batteries to power sensors that accurately provide biofeedback information that consumers are actively looking for.

3. Miracle mHealth Sensors 

Mhealth products are currently among some of the bestselling consumer sensor products today. Eliminating everyday health-related nuisances for many individuals, mhealth products enable consumers to measure blood pressure without a cuff or take blood sugar readings without a finger prick—and they rake in over $10 billion annually. While there is much R&D within this market, there has yet to be an FDA-approved product. Additionally, mhealth products leave room for significant “noise.” For products that measure blood oxygen content and skin conductivity, for example, applications to different wrist sizes and bone structures can result in significant reading variations.

For a full list of Farzaneh’s myths and misconceptions pertaining to the wearables market, check out the TechCrunch article here!

SOURCE: TechCrunch

About DoseSpot 
DoseSpot is a Surescripts certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.

Apple’s iPad Marks Healthcare Territory

Follow

Among the various verticals that Apple’s iPad now occupies, recent discussions suggests that the healthcare space may be benefiting the most. The topic of iPad use in healthcare surfaced at VentureBeat’s HealthBeat 2014 conference Tuesday, where Drchrono’s Daniel Kivatinos, Direct Dermatology’s Dr. Angela Walker and Welltok’s Michelle Snyder discussed the use of mobile technology like the iPad and Google Glass in today’s medical realm.

According to Kivatinos, Walker and Snyder, the iPad has had a huge impact on medical practices because it can be used for physician-oriented tasks previously restricted to desktop computers. After the official iPad launch in 2010, many doctors soon gravitated towards the device and incorporated its use into everyday medical practices.

Dr. Walker of Direct Dermatology added that she didn’t fully adopt the iPad in her dermatology practice until the iPad mini came out—she liked how it fit nicely in her white coat’s pocket. Welltok’s Snyder then pointed out that Drchrono was the first to create an EHR app for Google Glass. Some questions still remain around the use of Google Glass in the healthcare vertical, as privacy issues are teased out. The benefits, however, seem to be plentiful at the moment.

Kivatinos described Google Glass’ efficacy, in that quickly pressing Glass’ “record” button to capture a portion of a patient visit could be wildly helpful for both doctor and patient. Walker added that Google Glass might also be useful in patient education: “[surgery is] a discipline where doctors’ hands might be busy a lot and Glass can be helpful…In any setting where your hands are tied, it can be useful.” As discussions surrounding iPads and Google Glass in the medical field continue to multiply, one overall conclusion is very clear: mobile devices are changing the way healthcare professionals run their practices.

Did you miss out on HealthBeat 2014? Catch up on some interesting chats and happenings here!

SOURCE: VentureBeat

About DoseSpot 
DoseSpot is a Surescripts certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.